Pieris Pharmaceuticals Inc (PIRS)
NASDAQ
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 3.7M | 5.37M | 5.85M | 1.94M | 20.06M | 19.52M | 1.3M | 53k |
| Operating Income | -12.33M | -12.17M | -11.52M | -15.51M | 2.06M | 3.09M | -5.48M | -5.3M |
| Pre Tax Income | -10.34M | -9.74M | -8.1M | -13.18M | 3.98M | -10.75M | -4.58M | -4.89M |
| Net Income | -10.34M | -9.74M | -8.1M | -13.18M | 3.98M | -10.75M | -4.58M | -4.89M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -10.47M | -9.98M | -8.45M | -13.54M | 3.49M | 3.37M | -6.02M | -5.13M |
| EBITDA | -11.75M | -11.4M | -11.41M | -14.91M | 2.82M | 3.83M | -5.78M | -5.33M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 5.83M | 25.28M | 29.1M | 46.28M | 29.32M | 31.42M | 25.9M | 42.81M |
| Operating Income | -22.76M | -14.59M | -30.83M | -27.16M | -33.92M | -51.83M | -43.47M | -15.84M |
| Pre Tax Income | -22.64M | -16.54M | -27.07M | -25.47M | -37.07M | -45.74M | -33.28M | -24.54M |
| Net Income | -22.8M | -17.65M | -26.75M | -25.47M | -37.23M | -45.74M | -33.28M | -24.54M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -0.529 | -0.392 | -0.247 | -0.438 | -0.632 | -0.633 | -0.447 | -0.248 |
| EBIT | -22.64M | -16.7M | -29.03M | -27.18M | -37.58M | -45.74M | -34M | -12.48M |
| EBITDA | -22.4M | -14.23M | -30.26M | -26.53M | -31.82M | -49.43M | -41.17M | -14.04M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
